Report Detail
Global Pharmacogenomics (PGx) Market Size, Status and Forecast 2019-2025
- RnM2989207 |
- 20 February, 2019 |
- Global |
- 100 Pages |
- QYResearch |
- Pharma & Healthcare
Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.
In 2018, the global Pharmacogenomics (PGx) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Pharmacogenomics (PGx) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacogenomics (PGx) development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.
Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Other
Market segment by Application, split into
Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pharmacogenomics (PGx) status, future forecast, growth opportunity, key market and key players.
To present the Pharmacogenomics (PGx) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pharmacogenomics (PGx) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Polymerase Chain Reaction (PCR)
- 1.4.3 Microarray
- 1.4.4 Sequencing
- 1.4.5 Other
- 1.5 Market by Application
- 1.5.1 Global Pharmacogenomics (PGx) Market Share by Application (2014-2025)
- 1.5.2 Cardiovascular Diseases (CVD)
- 1.5.3 Central Nervous System (CNS)
- 1.5.4 Cancer/Oncology
- 1.5.5 Infectious Diseases
- 1.5.6 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Pharmacogenomics (PGx) Market Size
- 2.2 Pharmacogenomics (PGx) Growth Trends by Regions
- 2.2.1 Pharmacogenomics (PGx) Market Size by Regions (2014-2025)
- 2.2.2 Pharmacogenomics (PGx) Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Pharmacogenomics (PGx) Market Size by Manufacturers
- 3.1.1 Global Pharmacogenomics (PGx) Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI)
- 3.2 Pharmacogenomics (PGx) Key Players Head office and Area Served
- 3.3 Key Players Pharmacogenomics (PGx) Product/Solution/Service
- 3.4 Date of Enter into Pharmacogenomics (PGx) Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Pharmacogenomics (PGx) Market Size by Type (2014-2019)
- 4.2 Global Pharmacogenomics (PGx) Market Size by Application (2014-2019)
5 United States
- 5.1 United States Pharmacogenomics (PGx) Market Size (2014-2019)
- 5.2 Pharmacogenomics (PGx) Key Players in United States
- 5.3 United States Pharmacogenomics (PGx) Market Size by Type
- 5.4 United States Pharmacogenomics (PGx) Market Size by Application
6 Europe
- 6.1 Europe Pharmacogenomics (PGx) Market Size (2014-2019)
- 6.2 Pharmacogenomics (PGx) Key Players in Europe
- 6.3 Europe Pharmacogenomics (PGx) Market Size by Type
- 6.4 Europe Pharmacogenomics (PGx) Market Size by Application
7 China
- 7.1 China Pharmacogenomics (PGx) Market Size (2014-2019)
- 7.2 Pharmacogenomics (PGx) Key Players in China
- 7.3 China Pharmacogenomics (PGx) Market Size by Type
- 7.4 China Pharmacogenomics (PGx) Market Size by Application
8 Japan
- 8.1 Japan Pharmacogenomics (PGx) Market Size (2014-2019)
- 8.2 Pharmacogenomics (PGx) Key Players in Japan
- 8.3 Japan Pharmacogenomics (PGx) Market Size by Type
- 8.4 Japan Pharmacogenomics (PGx) Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Pharmacogenomics (PGx) Market Size (2014-2019)
- 9.2 Pharmacogenomics (PGx) Key Players in Southeast Asia
- 9.3 Southeast Asia Pharmacogenomics (PGx) Market Size by Type
- 9.4 Southeast Asia Pharmacogenomics (PGx) Market Size by Application
10 India
- 10.1 India Pharmacogenomics (PGx) Market Size (2014-2019)
- 10.2 Pharmacogenomics (PGx) Key Players in India
- 10.3 India Pharmacogenomics (PGx) Market Size by Type
- 10.4 India Pharmacogenomics (PGx) Market Size by Application
11 Central & South America
- 11.1 Central & South America Pharmacogenomics (PGx) Market Size (2014-2019)
- 11.2 Pharmacogenomics (PGx) Key Players in Central & South America
- 11.3 Central & South America Pharmacogenomics (PGx) Market Size by Type
- 11.4 Central & South America Pharmacogenomics (PGx) Market Size by Application
12 International Players Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Pharmacogenomics (PGx) Introduction
- 12.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.1.5 Abbott Laboratories Recent Development
- 12.2 Affymetrix, Inc.
- 12.2.1 Affymetrix, Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Pharmacogenomics (PGx) Introduction
- 12.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.2.5 Affymetrix, Inc. Recent Development
- 12.3 Assurex Health, Inc
- 12.3.1 Assurex Health, Inc Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Pharmacogenomics (PGx) Introduction
- 12.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.3.5 Assurex Health, Inc Recent Development
- 12.4 Astrazeneca
- 12.4.1 Astrazeneca Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Pharmacogenomics (PGx) Introduction
- 12.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.4.5 Astrazeneca Recent Development
- 12.5 GeneDX
- 12.5.1 GeneDX Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Pharmacogenomics (PGx) Introduction
- 12.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.5.5 GeneDX Recent Development
- 12.6 Illumina, Inc.
- 12.6.1 Illumina, Inc. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Pharmacogenomics (PGx) Introduction
- 12.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.6.5 Illumina, Inc. Recent Development
- 12.7 Laboratory Corporation of America Holdings
- 12.7.1 Laboratory Corporation of America Holdings Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Pharmacogenomics (PGx) Introduction
- 12.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.7.5 Laboratory Corporation of America Holdings Recent Development
- 12.8 Myriad Genetics, Inc.
- 12.8.1 Myriad Genetics, Inc. Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Pharmacogenomics (PGx) Introduction
- 12.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.8.5 Myriad Genetics, Inc. Recent Development
- 12.9 Pathway Genomics
- 12.9.1 Pathway Genomics Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Pharmacogenomics (PGx) Introduction
- 12.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.9.5 Pathway Genomics Recent Development
- 12.10 Pfizer, Inc
- 12.10.1 Pfizer, Inc Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Pharmacogenomics (PGx) Introduction
- 12.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2014-2019)
- 12.10.5 Pfizer, Inc Recent Development
- 12.11 Qiagen, Inc.
- 12.12 Rocheg
- 12.13 Teva Pharmaceutical Industries Ltd.
- 12.14 Thermo Fisher Scientific
- 12.15 Transgenomic, Inc.
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Pharmacogenomics (PGx) . Industry analysis & Market Report on Pharmacogenomics (PGx) is a syndicated market report, published as Global Pharmacogenomics (PGx) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pharmacogenomics (PGx) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
